Pharmaceutical composition containing botulinum B complex

Details Pharmaceutical composition containing botulinum B complex Pharmaceutical composition containing botulinum B complex

1994-10-03

1997-12-09

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

4241841, 4242341, 4242471, A61K 3908, A61K 3900, A61K 3800, A61K 3816

Patent

active

056960778

ABSTRACT:
A pharmaceutical preparation containing a complex consisting of type B botulinum neurotoxin and stabilizing proteins, both derived from C. botulinum, admixed with a pharmaceutically acceptable excipient is provided. The preparation is effective for inducing titratable, local, selective muscle denervation in a patient suffering from a disorder characterized by involuntary muscle spasm or contraction.

REFERENCES:
patent: 4932936 (1990-06-01), Dykstra et al.
Schantz, E.J., et al., Journal of the Association of Official Analytical Chemists, vol. 61, pp. 96-99, Jan. 1978.
Melling et al., Eye, vol. 2, pp. 16-23, 1988; "Clostridium Botulinum Toxins: Nature and Preparation for Clinical Use".
Kozaki et al., Infection and Immunity, vol. 10, pp. 750-756, 1974; "Purification and Some Properties of Progenitor Toxins . . . ".
Borodic et al., Annals of Neurology, vol. 31, p. 113, Jan. 1992; "Treatment of Spasticity with Botulinum Toxin" (letter).
Schantz, E. J. et al., Microbiol. Rev., vol. 56, pp. 80-99, Mar. 1992; "Properties and Use of Botulinum Toxin . . . ".
Schwarz, W., Arch. Lebensmittelhyg., vol. 30, pp. 29-33, 1979; (abstract); "Examinations on the stability."
Memin, B. et al., Rev. Neurol. (France), vol. 148, pp. 212-214, 1992; (abstract); "Effects on botulinum toxin on spasticity".
Saprykina, T.P. et al., Zh. Mikrobiol. Epidemiol. Immunobiol., vol. 57, pp. 86-91, 1980; (abstract); "Obtaining homogenous . . . ".
Clarke, C.E., Q. J. Med., vol. 82, pp. 197-205, Mar. 1992; "Therapeutic Potential of Botulinum Toxin in Neurological . . . ".
Jankovic, J. et al., New Eng. J. Med., vol. 324, pp. 1186-1194, 1991; "Therapeutic Uses of Botulinum Toxin".
Das, T.K. et al., Postgrad. Med. J., vol. 65, pp. 208-210, 1989; "Effect of treatment with botulinum toxin . . . ".
Das, T.K. et al., Brit. J. Clin. Practice, vol. 43, pp. 401-403, 1989; "Botulinum toxin in treating spasticity".
Goodnough et al. Stabilization of botulinum toxin type A during lyophilization. Applied and Environmental Microbiology. 58(10):3426-3428, Oct. 1992.
BOTOX in Physician's Desk Reference, Ed. David W. Sifton, Medical Economics Data Production Company, Montvale, New Jersey, 1994.
Pikal, Michael J., "BioPharm", Freeze-Drying of Proteins Part II: Formulation Selection, 20-30 (Oct. 1990).
Evans et al., Eur. J. Biochem. 154, 409-416 (1986).
Patterson-Curtis et al., Applied & Environmental Microbiology, vol. 55, No. 6., Jun. 1989, pp. 1544-1548.
Sellin et al., Acta Physiol Scand, vol. 119, 1983, pp. 127-133.
Singh, et al., mOlecular and Cellular Biochemistry, vol., 1989 pp. 87-95.

Affiliated with

Also associated with

Rating

Pharmaceutical composition containing botulinum B complex does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition containing botulinum B complex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing botulinum B complex will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1607652